AU549299B2 - Sustained release theophylline tablet - Google Patents

Sustained release theophylline tablet

Info

Publication number
AU549299B2
AU549299B2 AU70205/81A AU7020581A AU549299B2 AU 549299 B2 AU549299 B2 AU 549299B2 AU 70205/81 A AU70205/81 A AU 70205/81A AU 7020581 A AU7020581 A AU 7020581A AU 549299 B2 AU549299 B2 AU 549299B2
Authority
AU
Australia
Prior art keywords
sustained release
release theophylline
theophylline tablet
tablet
sustained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU70205/81A
Other languages
English (en)
Other versions
AU7020581A (en
Inventor
Dana Brooks
Stephen T. David
Claude E. Gallian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of AU7020581A publication Critical patent/AU7020581A/en
Application granted granted Critical
Publication of AU549299B2 publication Critical patent/AU549299B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU70205/81A 1980-05-06 1981-05-06 Sustained release theophylline tablet Expired AU549299B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US14742980A 1980-05-06 1980-05-06
US147429 1980-05-06
US24978781A 1981-04-01 1981-04-01
US249787 1981-04-01

Publications (2)

Publication Number Publication Date
AU7020581A AU7020581A (en) 1981-11-12
AU549299B2 true AU549299B2 (en) 1986-01-23

Family

ID=26844921

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70205/81A Expired AU549299B2 (en) 1980-05-06 1981-05-06 Sustained release theophylline tablet

Country Status (17)

Country Link
AT (1) AT380789B (de)
AU (1) AU549299B2 (de)
CA (1) CA1165241A (de)
CY (1) CY1368A (de)
DE (1) DE3117756A1 (de)
DK (1) DK155976C (de)
FI (1) FI811356L (de)
FR (1) FR2484253A1 (de)
GB (1) GB2078518B (de)
HK (1) HK4288A (de)
IE (1) IE51157B1 (de)
IT (1) IT1209867B (de)
KE (1) KE3722A (de)
LU (1) LU83342A1 (de)
NL (1) NL8102168A (de)
SE (1) SE452550B (de)
SG (1) SG30987G (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
US4753945A (en) * 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
FR2595945B1 (fr) * 1986-03-19 1990-01-19 Doms Laboratoires Comprime-retard de theophylline a base de p.v.c., et son procede de preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL297088A (de) * 1961-01-31
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3723614A (en) * 1971-01-06 1973-03-27 Ciba Geigy Ag Maltese-cross scored tablet
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion

Also Published As

Publication number Publication date
SE8102814L (sv) 1981-11-07
CA1165241A (en) 1984-04-10
KE3722A (en) 1987-04-30
FI811356L (fi) 1981-11-07
ATA202081A (de) 1985-12-15
HK4288A (en) 1988-01-29
IE51157B1 (en) 1986-10-15
IT8148406A0 (it) 1981-05-06
DE3117756A1 (de) 1982-04-29
DK200181A (da) 1981-11-07
AT380789B (de) 1986-07-10
DK155976C (da) 1989-10-30
LU83342A1 (fr) 1982-01-20
FR2484253B1 (de) 1983-06-03
FR2484253A1 (fr) 1981-12-18
GB2078518A (en) 1982-01-13
NL8102168A (nl) 1981-12-01
GB2078518B (en) 1984-04-11
SE452550B (sv) 1987-12-07
CY1368A (en) 1987-08-07
SG30987G (en) 1987-07-17
IT1209867B (it) 1989-08-30
DK155976B (da) 1989-06-12
IE810989L (en) 1981-11-06
DE3117756C2 (de) 1992-11-26
AU7020581A (en) 1981-11-12

Similar Documents

Publication Publication Date Title
AU558500B2 (en) Controlled slow release tablet
AU545962B2 (en) Centre release buckle
GB8500639D0 (en) Fast-starting sustained release tablet
AU544965B2 (en) Controlled release potassium dosage form
AU546249B2 (en) Slow release tablet formulation
AU8947082A (en) Tablet dispenser
AU546858B2 (en) s
AU6203386A (en) Controlled release tablet
AU557693B2 (en) Pharmaceutical sustained release compounds
GB2090185B (en) Tablet press
AU561627B2 (en) Tablet dispenser
AU552561B2 (en) Roll stand
AU554592B2 (en) Imidazolyl-phenyl amidines
AU547803B2 (en) s
AU2714284A (en) Self-disintegrating tablet
AU542824B2 (en) Sustained release pharmaceuticals
AU7704381A (en) Tablet dispenser
AU549299B2 (en) Sustained release theophylline tablet
AU1810683A (en) Constant release theophylline tablets
AU7639881A (en) Combined harrow-plow
ZA812861B (en) Sustained release theophylline tablet having reduced bulk
AU536558B2 (en) Engageable article
AU535210B2 (en) Release mechanism
AU7572481A (en) Camera stand
AU534472B2 (en) Chlorination tablets

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired